Cargando…

Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)

Phyllodes tumors of the breast are biphasic tumors consisting from an epithelial component and a mesenchymal component. Usually, the mesenchymal component of the tumor is the one who dictates the malignancy of the biphasic proliferation. Presence of the malignancy of the both, epithelial [under the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nistor-Ciurba, Codruţ-Cosmin, Şomcutian, Oana, Lisencu, Ioan Cosmin, Ignat, Florin Laurenţiu, Lazăr, Gabriel Lucian, Eniu, Dan Tudor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728119/
https://www.ncbi.nlm.nih.gov/pubmed/32747903
http://dx.doi.org/10.47162/RJME.61.1.14
_version_ 1783621204457816064
author Nistor-Ciurba, Codruţ-Cosmin
Şomcutian, Oana
Lisencu, Ioan Cosmin
Ignat, Florin Laurenţiu
Lazăr, Gabriel Lucian
Eniu, Dan Tudor
author_facet Nistor-Ciurba, Codruţ-Cosmin
Şomcutian, Oana
Lisencu, Ioan Cosmin
Ignat, Florin Laurenţiu
Lazăr, Gabriel Lucian
Eniu, Dan Tudor
author_sort Nistor-Ciurba, Codruţ-Cosmin
collection PubMed
description Phyllodes tumors of the breast are biphasic tumors consisting from an epithelial component and a mesenchymal component. Usually, the mesenchymal component of the tumor is the one who dictates the malignancy of the biphasic proliferation. Presence of the malignancy of the both, epithelial [under the form of invasive carcinoma or ductal carcinoma in situ (DCIS)] and mesenchymal components is very rare. Most of the data available from the literature refers to single case presentations. This paper presents the experience of Prof. Dr. Ion Chiricuţă Oncological Institute (IOCN), Cluj-Napoca, Romania, with the malignant phyllodes tumors with both epithelial and mesenchymal components showing malignancy. Over two decades (1999–2018), four cases of malignant phyllodes tumors with concomitant epithelial and mesenchymal malignancy were found and presented as a case series. Two out of four cases were malignant phyllodes tumors harboring invasive breast carcinomas (one case with associated DCIS and one case of pure invasive carcinoma) and two cases were malignant phyllodes tumors with the epithelial component showing DCIS. Average follow-up period was 67 months (from 39 to 132 months) with a disease-free survival of 58 months.
format Online
Article
Text
id pubmed-7728119
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
record_format MEDLINE/PubMed
spelling pubmed-77281192020-12-18 Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma) Nistor-Ciurba, Codruţ-Cosmin Şomcutian, Oana Lisencu, Ioan Cosmin Ignat, Florin Laurenţiu Lazăr, Gabriel Lucian Eniu, Dan Tudor Rom J Morphol Embryol Original Paper Phyllodes tumors of the breast are biphasic tumors consisting from an epithelial component and a mesenchymal component. Usually, the mesenchymal component of the tumor is the one who dictates the malignancy of the biphasic proliferation. Presence of the malignancy of the both, epithelial [under the form of invasive carcinoma or ductal carcinoma in situ (DCIS)] and mesenchymal components is very rare. Most of the data available from the literature refers to single case presentations. This paper presents the experience of Prof. Dr. Ion Chiricuţă Oncological Institute (IOCN), Cluj-Napoca, Romania, with the malignant phyllodes tumors with both epithelial and mesenchymal components showing malignancy. Over two decades (1999–2018), four cases of malignant phyllodes tumors with concomitant epithelial and mesenchymal malignancy were found and presented as a case series. Two out of four cases were malignant phyllodes tumors harboring invasive breast carcinomas (one case with associated DCIS and one case of pure invasive carcinoma) and two cases were malignant phyllodes tumors with the epithelial component showing DCIS. Average follow-up period was 67 months (from 39 to 132 months) with a disease-free survival of 58 months. Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2020 2020-06-02 /pmc/articles/PMC7728119/ /pubmed/32747903 http://dx.doi.org/10.47162/RJME.61.1.14 Text en Copyright © 2020, Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
spellingShingle Original Paper
Nistor-Ciurba, Codruţ-Cosmin
Şomcutian, Oana
Lisencu, Ioan Cosmin
Ignat, Florin Laurenţiu
Lazăr, Gabriel Lucian
Eniu, Dan Tudor
Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)
title Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)
title_full Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)
title_fullStr Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)
title_full_unstemmed Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)
title_short Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)
title_sort malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728119/
https://www.ncbi.nlm.nih.gov/pubmed/32747903
http://dx.doi.org/10.47162/RJME.61.1.14
work_keys_str_mv AT nistorciurbacodrutcosmin malignantphyllodestumorsofthebreastassociatingmalignancyofbothmesenchymalandepithelialcomponentsinvasiveorinsituductalcarcinoma
AT somcutianoana malignantphyllodestumorsofthebreastassociatingmalignancyofbothmesenchymalandepithelialcomponentsinvasiveorinsituductalcarcinoma
AT lisencuioancosmin malignantphyllodestumorsofthebreastassociatingmalignancyofbothmesenchymalandepithelialcomponentsinvasiveorinsituductalcarcinoma
AT ignatflorinlaurentiu malignantphyllodestumorsofthebreastassociatingmalignancyofbothmesenchymalandepithelialcomponentsinvasiveorinsituductalcarcinoma
AT lazargabriellucian malignantphyllodestumorsofthebreastassociatingmalignancyofbothmesenchymalandepithelialcomponentsinvasiveorinsituductalcarcinoma
AT eniudantudor malignantphyllodestumorsofthebreastassociatingmalignancyofbothmesenchymalandepithelialcomponentsinvasiveorinsituductalcarcinoma